Imeik Technology Development Co

Imeik Technology Development Co P/TBV

The Price to Tangible Book Value (P/TBV) of Imeik Technology Development Co (300896.SZ) as of Oct 17, 2026 is 7.12. In the previous year, Price to Tangible Book Value (P/TBV) was 5.71 — a change of 24.66% (higher).

P/TBV

7.12

YoY

24.66%

Last updated:

Price to Tangible Book Value (P/TBV) of Imeik Technology Development Co is 2025 7.12 . Price to Tangible Book Value (P/TBV) of Imeik Technology Development Co was 2024 5.71 . It decreases by 24.66% higher compared to the previous year.

The Imeik Technology Development Co P/TBV history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/TBV
Date
P/TBV
Jan 1, 2018
108.65 CNY
Jan 1, 2019
65.29 CNY
Jan 1, 2020
9.36 CNY
Jan 1, 2021
8.43 CNY
Jan 1, 2022
7.72 CNY
Jan 1, 2023
7.07 CNY
Jan 1, 2024
5.71 CNY
Jan 1, 2025
7.12 CNY
The Imeik Technology Development Co P/TBV history
YEARP/TBVYoY
7.12+24.66%
5.71-19.17%
7.07-8.41%
7.72-8.52%
8.43-9.85%
9.36-85.67%
65.29-39.91%
108.65-18.86%
133.90-17.46%
162.22-41.87%
279.04-41.94%
480.59—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Imeik Technology Development Co Stock analysis

What does Imeik Technology Development Co do? Imeik Technology Development Co Ltd is a biotechnology company based in Beijing, China, operating within the healthcare sector. The company focuses on the research, development, and industrialization of biomedical materials, particularly recombinant proteins and peptides. It has established a product technology transformation platform for biomedical materials, including medical chitosan and polylactic acid. Imeik has successfully industrialized injection-type sodium hyaluronate series products and polydioxanone facial implants. Its self-developed products are primarily designed for the repair of facial and neck skin folds, with clinical applications spanning medical cosmetology, surgical repair, and the treatment of metabolic diseases. The company went public on the Shenzhen Stock Exchange on September 28, 2020, with ticker 300896.SZ and ISIN CNE100004868. Imeik currently employs 713 full-time staff and operates exclusively within the Chinese market. Its website is www.imeik.net, providing information on its products and services. The company emphasizes the development and transformation of biomedical materials, aiming to advance biomedicine through its specialized focus on recombinant proteins and peptides. It has developed a range of products that address specific medical and cosmetic needs, contributing to its position in the healthcare industry. Imeik Technology Development Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Imeik Technology Development Co stock

Price to Tangible Book Value (P/TBV) of Imeik Technology Development Co is 7.12 in 2025.

Price to Tangible Book Value (P/TBV) of Imeik Technology Development Co changed from 5.71 to 7.12, representing a 24.66% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Price to Tangible Book Value (P/TBV) Imeik Technology Development Co since 2006 – with annual values, charts, and detailed analysis.

P/TBV compares the stock price to tangible book value per share, excluding goodwill and intangibles. It provides a conservative asset-based valuation.

To evaluate Price to Tangible Book Value (P/TBV)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Price to Tangible Book Value (P/TBV).

A 'good' varies by industry and company stage. On Eulerpool, you can compare Price to Tangible Book Value (P/TBV)'s Imeik Technology Development Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Imeik Technology Development Co

All Key Metrics — Imeik Technology Development Co